The increased revolver provides PAHC with additional liquidity headroom for general corporate purposes, including working capital and potential acquisitions. Monitor upcoming quarterly filings for any deployment of this capacity and for any changes in leverage ratios.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 1 $54.66entry
- T+1 · 7mo ago −0.38%α −0.04% · $54.45
- T+5 · 6mo ago −27.13%α −29.47% · $39.83
- T+20 · 6mo ago −45.58%α −50.85% · $29.74
- T+60 · 4mo ago −33.46%α −36.53% · $36.37
Price Chart
How similar events traded
Executive Summary
Phibro Animal Health Corp. entered into Amendment No. 1 to its existing Credit Agreement, increasing its revolving credit commitment by $125 million from $310 million to $435 million. The amendment was executed with Coöperatieve Rabobank U.A., New York Branch, as administrative agent, and multiple incremental revolving lenders. This is a routine liquidity enhancement that increases the company's financial flexibility without any indication of distress or material change in operations.
Key Financial Metrics
Key Facts
- Revolving credit commitment increased by $125,000,000 from $310,000,000 to $435,000,000
- Amendment No. 1 dated April 28, 2026
- Incremental revolving lenders include Rabobank, Bank of America, Compeer Financial, Citibank, Farm Credit East, City National Bank, BMO Bank, and others
- Upfront fee of 0.15% paid to each incremental revolving lender
- No Default or Event of Default existed at effectiveness
- Pro Forma Compliance with financial covenants was satisfied
- Existing guarantees and security interests were reaffirmed
Financial Impact
Revolving credit facility increased by $125,000,000 to $435,000,000 total
Risk Factors
- Increased debt capacity could lead to higher leverage if fully drawn
- No material change in business fundamentals from this filing alone
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-052956 |
| Document: tm2613052d1_8k.htm | 0001104659-26-052956 |
| Document: 0001104659-26-052956-index-headers.html | 0001104659-26-052956 |
| Document: 0001104659-26-052956-index.html | 0001104659-26-052956 |
| Document: 0001104659-26-052956.txt | 0001104659-26-052956 |
Track record
9 reports on PAHC
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +37.96% at T+20 after the Apr 27, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 4, 202612d ago 8-K Neutral 4/10 Entry $35.40 to $35.46 Now $35.02 −1.07% ▲ +0.17% −3.12% vs SPY
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $39.43 to $35.15 Now $35.02 −11.18% ▼ −10.85% −9.94% vs SPY
- Oct 19, 202628d ago SC 13G/A Bearish 5/10 Entry $38.80 to $38.38 Now $35.02 +9.74% ▲ +1.08% +1.16% vs SPY
- Jul 28, 202615w ago 8-K Neutral 2/10 Entry $36.95 to $36.01 Now $35.02 −5.22% ▼ −2.54% −8.07% vs SPY
- Jun 26, 202620w ago 8-K Neutral 2/10 Entry $31.81 to $34.13 Now $35.02 +10.09% ▲ +7.29% +5.91% vs SPY
- May 6, 202627w ago 8-K Bullish 6/10 Entry $43.16 to $35.26 Now $35.02 −18.86% ▼ −18.30% −19.81% vs SPY
- May 5, 202627w ago 8-K Neutral 2/10 Entry $58.50 to $36.58 Now $35.02 −40.14% ▼ −37.47% −38.60% vs SPY
- Apr 30, 202628w ago 8-K Neutral 4/10 Viewing Entry $54.66 to $39.83 Now $35.02 −35.93% ▼ −27.13% −29.47% vs SPY
- Apr 27, 202629w ago 8-K Bearish 5/10 Entry $54.29 to $54.68 Now $35.02 +35.49% ▼ −0.72% +0.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers